Initial psychometric validation of the Caregiver Atopic Dermatitis Control Tool
Clinical and Experimental Dermatology · 2026
DOI: 10.1093/ced/llag289 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Clinical and Experimental Dermatology, 2026. Verfasst von Milie M Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Oregon Health & Science University, Portland, OR, USA. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Caregivers. Die Arbeit nennt 9 Literaturangaben. Gefördert von: Oregon Health & Science Institutional Review Board.
Abstract (Originalsprache)
The Atopic Dermatitis Control Tool (ADCT) is a validated six-item tool used in clinical trials to assess eczema control in adolescents and adults. Two versions of the ADCT were recently developed using a US Food and Drug Administration-recommended methodology. One is intended for use with caregivers of children aged 6 months to 11 years (the Caregiver ADCT; score range 0–24; higher scores indicate worse control; recall period the past 7 days). The other, the Child Eczema Control Tool (ECT), is intended for use with children aged 8 to 11 years. We conducted the first psychometric validation of the Caregiver ADCT (first 100 caregivers recruited), which demonstrated no floor or ceiling effects in response distributions, except for a floor effect for ‘sleep-trouble nights’ (47% selected the least severe option; n = 47/100). There were strong inter-item correlations (r ≥ 0.57; P < 0.001) and construct validity (r ≥ 0.59; P < 0.001), consistent with a priori hypotheses. The Caregiver ADCT showed strong internal consistency (Cronbach’s α = 0.92, 95% confidence interval 0.90–0.94). A score ≥ 7 was identified as the optimal threshold for identifying children whose eczema was ‘not in control’.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Oregon Health & Science University, Portland, OR, USA.
- Department of Dermatology and Pediatrics, Oregon Health & Science University, Portland, OR, USA.
- Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
- Sanofi, Cambridge, MA, USA.
- Sanofi, Gentilly, France.
- Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
ORCID-Profile: Milie M Fang, Jordan Gillespie, Robyn Okereke, Julie Dhossche, Emile Latour, Chien-Chia Chuang, Jerome Msihid, Zhixiao Wang, Eric L Simpson
Förderung
- Oregon Health & Science Institutional Review Board
Zitieren
APA
Fang, M. M., Gillespie, J., Okereke, R., Dhossche, J., Latour, E., Chuang, C. C., Msihid, J., Wang, Z., & Simpson, E. L. (2026). Initial psychometric validation of the Caregiver Atopic Dermatitis Control Tool. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag289
Vancouver
Fang MM, Gillespie J, Okereke R, Dhossche J, Latour E, Chuang CC, et al. Initial psychometric validation of the Caregiver Atopic Dermatitis Control Tool. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag289
BibTeX
@article{Fang2026,
author = {Fang, Milie M and Gillespie, Jordan and Okereke, Robyn and Dhossche, Julie and Latour, Emile and Chuang, Chien-Chia and Msihid, Jerome and Wang, Zhixiao and Simpson, Eric L},
title = {Initial psychometric validation of the Caregiver Atopic Dermatitis Control Tool},
journal = {Clinical and Experimental Dermatology},
year = {2026},
doi = {10.1093/ced/llag289}
}
EUVIMED